ATXI CIK: 1644963

Avenue Therapeutics Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
3.96
FY22:
6.85
FY23:
1.85
FY24:
2.67
FY25:
2.93
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
3.96
FY22:
6.85
FY23:
1.85
FY24:
2.67
FY25:
2.93

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
0.51
FY22:
3.58
FY23:
1.20
FY24:
0.82
FY25:
1.10
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.45
FY22:
3.91
FY23:
1.58
FY24:
2.80
FY25:
1.83
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
3.96
FY22:
7.48
FY23:
2.78
FY24:
3.61
FY25:
2.93

All amounts in millions USD Data sources:SEC EDGARTwelve Data